FDA Inspection 1156516 — WCG IRB, Inc
The FDA completed an inspection of WCG IRB, Inc on Nov 5, 2021 in Puyallup, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 5, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Puyallup, WA (United States)
Additional Details
IRB